Press Releases

06/19/2019

Menarini Silicon Biosystems Introduces Use of DEPArray System for Challenging Flow Cytometry Applications at CYTO Congress

Digital cell sorting technology enables greater precision and accuracy for samples with rare targets and low cell counts

continue →

Topics: deparray, cell sorting, flow cytometry, rare cells

03/27/2019

New CellSearch Data To Be Presented at AACR Deepens Understanding of Metastatic Breast Cancer

Northwestern Researchers Use Gold-Standard Liquid Biopsy Technology to Identify Potential New Biomarker

continue →

Topics: deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer, lynphoma, CTC cluster, melanoma

03/12/2019

Menarini Silicon Biosystems Develops New Assay Workflow for Circulating Multiple Myeloma Cells

Technology to Be Introduced at the Molecular Medicine Tri-Conference May Offer Alternative to Invasive Bone Marrow Biopsy for Monitoring Disease Progression

continue →

Topics: FFPE, deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, Multiple myeloma, CMMCs

11/27/2018

Single-Cell Genomic Analysis of Blood Cancers to be Highlighted at American Society of Hematology Meeting

DEPArray Technology Used for Detection and Isolation of Lymphoma and Multiple Myeloma Cells

continue →

Topics: single-cell isolation, deparray, copy number alteration, Multiple myeloma, classical Hodgkin Lymphoma, Reed-Sternberg (HRS) Cells

04/3/2017

Menarini-Silicon Biosystems Completes Acquisition of CELLSEARCH® Assets

Liquid Biopsy Test for Circulating Tumor Cells Marks Its First Entry into U.S. Diagnostics Market

continue →

Topics: CTCs, deparray, CELLSEARCH, acquisition, CTC test, Liquid biopsy

12/20/2016

Menarini-Silicon Biosystems to Acquire CELLSEARCH® CTC System

Only FDA-Cleared CTC test to join Company’s Portfolio of Diagnostics

continue →

Topics: CTCs, single-cell isolation, deparray, CELLSEARCH

11/25/2016

DEPArray™ Single-Cell Isolation Technology Enables Researchers to Develop a Model for Predicting Response to Treatment in Patients with Lung Cancer

Genetic Profiles of Circulating Tumor Cells May Predict Drug Resistance and Clinical Outcomes

continue →

Topics: CTCs, lung cancer, deparray, SCLC